These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 3457041)

  • 21. Expression of CD1 and HLA-DR by Langerhans cells (LC) in oral lichenoid drug eruptions (LDE) and idiopathic oral lichen planus (LP).
    McCartan BE; Lamey PJ
    J Oral Pathol Med; 1997 Apr; 26(4):176-80. PubMed ID: 9176792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistological analysis of experimental gingivitis in humans.
    Seymour GJ; Gemmell E; Walsh LJ; Powell RN
    Clin Exp Immunol; 1988 Jan; 71(1):132-7. PubMed ID: 3280178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of Langerhans cells in oral hairy leukoplakia, an AIDS-associated lesion.
    Daniels TE; Greenspan D; Greenspan JS; Lennette E; Schiødt M; Petersen V; de Souza Y
    J Invest Dermatol; 1987 Aug; 89(2):178-82. PubMed ID: 3110300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Langerhans cells: simultaneous use of sera to intermediate filaments, T6 and HLA-DR antigens on oral mucosa, human epidermis and their tumours.
    Löning T; Caselitz J; Seifert G; Weber K; Osborn M
    Virchows Arch A Pathol Anat Histopathol; 1982; 398(2):119-28. PubMed ID: 6819705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrastructural localization of HLA-DR and HLA-DQ molecules in Langerhans cells and B cells: an immunoelectronmicroscopic study.
    Vermeer BJ; Mommaas AM; Wijsman MC; Koning F; Claas FH
    Reg Immunol; 1988; 1(2):85-91. PubMed ID: 3275214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia.
    Hughes RG; Norval M; Howie SE
    J Clin Pathol; 1988 Mar; 41(3):253-9. PubMed ID: 2834416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro modulation of T6 expression on gingival Langerhans cells by interleukin-1 inhibitors and ETAF.
    Walsh LJ; Lander PE; Seymour GJ; Powell RN
    J Dent Res; 1987 Mar; 66(3):766-9. PubMed ID: 3112200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
    Pesando JM; Graf L
    J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the gingival status by quantification of the T6 (CD1a) and HLA-DR antigens].
    Sagredo E; Pino A; Ibañez P
    J Biol Buccale; 1990 Sep; 18(3):163-8. PubMed ID: 1701432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain.
    Hansson GK; Jonasson L; Holm J; Claesson-Welsh L
    Clin Exp Immunol; 1986 May; 64(2):261-8. PubMed ID: 3527502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential major histocompatibility complex class II locus expression on human laryngeal epithelium.
    Rees LE; Ayoub O; Haverson K; Birchall MA; Bailey M
    Clin Exp Immunol; 2003 Dec; 134(3):497-502. PubMed ID: 14632757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of HLA class II antigens in marginal periodontitis of patients with Down's syndrome.
    Søhoel DC; Johannessen AC; Kristoffersen T; Nilsen R
    Eur J Oral Sci; 1995 Aug; 103(4):207-13. PubMed ID: 7552950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
    Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
    Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of class II HLA antigens (HLA-DR, DQW1, DQW3) in normal skin and cutaneous pathology].
    Gomes M; Schmitt D; Dezutter-Dambuyant C; Capra JD; Thivolet J
    Pathol Biol (Paris); 1986 Mar; 34(3):157-64. PubMed ID: 3517784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of inflammatory cell phenotypes in human oral carcinomas by means of monoclonal antibodies.
    Löning T; Broemel H; Becker WM; Otto HF
    Arch Oral Biol; 1983; 28(12):1093-100. PubMed ID: 6607724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.
    Momburg F; Koretz K; Von Herbay A; Möller P
    Clin Exp Immunol; 1988 Jun; 72(3):367-72. PubMed ID: 3048805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of HLA-DQ expression by keratinocytes and Langerhans cells in normal and premalignant cervical epithelium.
    Mota FF; Rayment NB; Kanan JH; Singer A; Chain BM
    Tissue Antigens; 1998 Sep; 52(3):286-93. PubMed ID: 9802611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MHC antigen expression in human oral squamous carcinoma cell lines.
    Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
    J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activation of Langerhans cells in oral lichen planus.
    Farthing PM; Matear P; Cruchley AT
    J Oral Pathol Med; 1990 Feb; 19(2):81-5. PubMed ID: 1692876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.
    Aglietta M; Piacibello W; Stacchini A; Dezza L; Sanavio F; Malavasi F; Infelise V; Resegotti L; Gavosto F
    Cancer Res; 1986 Apr; 46(4 Pt 1):1783-7. PubMed ID: 3456268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.